XBiotech clinical trials we track

Check company identity source

Phase 2 3 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 3 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Assessment of Spondyloarthritis International Society (ASAS) criteria will be used to determine proportion of subjects achieving 40% Improvement (ASAS40 response). After: Measure: Percentage of participants achieving ASAS40..

Planned enrollment increased by 90 participants

Before: 60 participants (planned). After: 150 participants (planned).

Primary completion date changed

Before: 28 Feb 2027. After: Sep 2028.

Check registry source